series-a
Stage
1
Investors
About
Stingray Bio develops oncology therapeutics by targeting neglected but essential cancer kinases to generate next-generation treatments for cancer patients.
Explore Stingray Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.